These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 17588407)

  • 1. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.
    Lee PC; Port JL; Korst RJ; Liss Y; Meherally DN; Altorki NK
    Ann Thorac Surg; 2007 Jul; 84(1):177-81. PubMed ID: 17588407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA.
    Annema JT; Hoekstra OS; Smit EF; Veseliç M; Versteegh MI; Rabe KF
    Lung Cancer; 2004 Apr; 44(1):53-60. PubMed ID: 15013583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.
    Cerfolio RJ; Bryant AS; Ojha B
    J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer.
    von Haag DW; Follette DM; Roberts PF; Shelton D; Segel LD; Taylor TM
    J Surg Res; 2002 Apr; 103(2):160-4. PubMed ID: 11922730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: analysis of 212 patients.
    Iskender I; Kapicibasi HO; Kadioglu SZ; Sevilgen G; Tezel C; Kosar' A; Atasalihi A; Kir A
    Acta Chir Belg; 2012; 112(3):219-25. PubMed ID: 22808763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.
    Ebihara A; Nomori H; Watanabe K; Ohtsuka T; Naruke T; Uno K; Kuwahira I; Eguchi K
    Jpn J Clin Oncol; 2006 Nov; 36(11):694-8. PubMed ID: 17068084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
    Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
    Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
    D'Cunha J; Herndon JE; Herzan DL; Patterson GA; Kohman LJ; Harpole DH; Kernstine KH; Kern JA; Green MR; Maddaus MA; Kratzke RA;
    Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?
    Casiraghi M; Travaini LL; Maisonneuve P; Tessitore A; Brambilla D; Agoglia BG; Guarize J; Spaggiari L
    Eur J Cardiothorac Surg; 2011 Apr; 39(4):e38-43. PubMed ID: 21242094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
    Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
    J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation.
    Shim SS; Han J
    Ann Nucl Med; 2010 Jun; 24(5):357-62. PubMed ID: 20306161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.
    Trister AD; Pryma DA; Xanthopoulos E; Kucharczuk J; Sterman D; Rengan R
    Am J Clin Oncol; 2014 Apr; 37(2):135-9. PubMed ID: 23111361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue.
    Chung MK; Jeong HS; Son YI; So YK; Park GY; Choi JY; Hyun SH; Kim HJ; Ko YH; Baek CH
    Ann Surg Oncol; 2009 Nov; 16(11):3111-7. PubMed ID: 19609618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.
    De Leyn P; Lardinois D; Van Schil PE; Rami-Porta R; Passlick B; Zielinski M; Waller DA; Lerut T; Weder W
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):1-8. PubMed ID: 17448671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with true pathologic stage I non-small cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multimodal treatment of non small cell lung cancer].
    Stoelben E; Digel W; Henke M; Passlick B
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role.
    Vesselle H; Freeman JD; Wiens L; Stern J; Nguyen HQ; Hawes SE; Bastian P; Salskov A; Vallières E; Wood DE
    Clin Cancer Res; 2007 Jun; 13(11):3255-63. PubMed ID: 17545531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.